News und Analysen
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft: Annual General Meeting approves all agenda items
Why Shares of HealthEquity Are Up Tuesday
Shares of HealthEquity (NASDAQ: HQY) were up more than 13% Tuesday morning after the healthcare services company reported earnings after the markets closed on Monday. The stock is up more than 9% so
Why Shares of Amedisys Are Jumping Monday
Shares of home healthcare solutions company Amedisys (NASDAQ: AMED) were up more than 14% Monday morning after the company reported that it had received an unsolicited buyout offer from Optum, a
Acadia Healthcare Appoints Heather Dixon as Chief Financial Officer
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced Heather Dixon has been appointed Chief Financial Officer (CFO), effective July 10, 2023. Dixon succeeds
EQS-Adhoc: GN Store Nord A/S announces successful completion of directed issue and private placing of new shares and existing treasury shares, raising gross proceeds of approximately DKK 2.75 bn
Why Shares of Organogenesis Climbed Wednesday
Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and
EQS-Adhoc: GN Store Nord A/S announces plan to strengthen its capital structure to execute growth opportunities including a directed issue and private placing of a total of approximately 17 million shares
Why Integra LifeSciences Stock Is Crashing Today
Shares of Integra LifeSciences (NASDAQ: IART) were crashing on Tuesday, with the stock falling 20.7% as of 3:39 p.m. ET. The steep decline came after the company revealed in a regulatory filing that
Acadia Healthcare Names Judith Scimone Company’s New Chief Human Resources Officer
Acadia Healthcare Company Inc. (NASDAQ: ACHC) today announced that Judith Scimone has joined Acadia as the Company’s Chief Human Resources Officer (CHRO). In this role, she will shape and advance
EQS-News: RHÖN-KLINIKUM AG looks back on successful Q1 2023
EQS-News: SARTORIUS AG: Sartorius announces CFO transition
EQS-Adhoc: GN Store Nord A/S: GN Store Nord delivered 7% organic revenue growth driven by strong market share gains. Full year guidance upgraded
EQS-News: SARTORIUS AG: First quarter of Sartorius characterized by normalization of demand; full-year outlook confirmed
EQS-News: Gerresheimer AG: Gerresheimer AG successfully completes EUR 271.6 million capital increase
EQS-Adhoc: Gerresheimer AG: Gerresheimer AG issues 3,140,000 million new shares at a placement price of EUR 86.50 per new share
EQS-News: Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares
EQS-Adhoc: Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares
EQS-News: SARTORIUS AG: Sartorius to acquire Polyplus
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2022
EQS-News: SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
EQS-News: SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast
Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital
LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren
LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich medizintechnische Innovationen, gab heute bekannt, dass es die 510(k)-Freigabe von der US-amerikanischen Food and Drug
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™